NK cells control breast cancer and related cancer stem cell hematological spread

References

• Bignold LP, Coghlan BL, Jersmann HP. Hansemann, Boveri, chromosomes and the gametogenesis-related theories of tumours. Cell Biol Int 2006; 30:640-4; PMID:16753311; http://dx.doi.org/10.1016/j.cellbi.2006.04.002
   PubMed Web of Science ®Google Scholar
• Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004; 51:1-28; PMID:15207251; http://dx.doi.org/10.1016/j.critrevonc.2004.04.007
   PubMed Web of Science ®Google Scholar
• Knudson AG, Jr., Strong LC, Anderson DE. Heredity and cancer in man. Prog Med Genet 1973; 9:113-58; PMID:4351406
   PubMedGoogle Scholar
• Tomasetti C, Vogelstein B. Cancer risk: role of environment-response. Science 2015; 347:729-31; PMID:25678653; http://dx.doi.org/10.1126/science.aaa6592
   PubMed Web of Science ®Google Scholar
• Fornari C, Beccuti M, Lanzardo S, Conti L, Balbo G, Cavallo F, Calogero RA, Cordero F. A mathematical-biological joint effort to investigate the tumor-initiating ability of Cancer Stem Cells. PLoS One 2014; 9:e106193; PMID:25184361; http://dx.doi.org/10.1371/journal.pone.0106193
   PubMed Web of Science ®Google Scholar
• Cordero F, Beccuti M, Fornari C, Lanzardo S, Conti L, Cavallo F, Balbo G, Calogero R. Multi-level model for the investigation of oncoantigen-driven vaccination effect. BMC Bioinformatics 2013; 14 (Suppl 6):S11; PMID:23734974; http://dx.doi.org/10.1186/1471-2105-14-S6-S11
   PubMed Web of Science ®Google Scholar
• Conti L, Ruiu R, Barutello G, Macagno M, Bandini S, Cavallo F, Lanzardo S. Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice. Biomed Res Int 2014; 2014:534969; PMID:25136593; http://dx.doi.org/10.1155/2014/534969
   PubMed Web of Science ®Google Scholar
• Nicolini A, Ferrari P, Fini M, Borsari V, Fallahi P, Antonelli A, Berti P, Carpi A, Miccoli P. Stem cells: their role in breast cancer development and resistance to treatment. Curr Pharm Biotechnol 2011; 12:196-205; PMID:21044007; http://dx.doi.org/10.2174/138920111794295657
   PubMed Web of Science ®Google Scholar
• Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008; 456:593-8; PMID:19052619; http://dx.doi.org/10.1038/nature07567
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-11; PMID:11689955; http://dx.doi.org/10.1038/35102167
   PubMed Web of Science ®Google Scholar
• Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23:675-99; PMID:17645413; http://dx.doi.org/10.1146/annurev.cellbio.22.010305.104154
   PubMed Web of Science ®Google Scholar
• Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3:895-902; PMID:14737120; http://dx.doi.org/10.1038/nrc1232
   PubMed Web of Science ®Google Scholar
• Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005; 15:494-501; PMID:16084092; http://dx.doi.org/10.1016/j.tcb.2005.07.004
   PubMed Web of Science ®Google Scholar
• Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, Mortini P, Ferrone S, Doglioni C, Marincola FM, et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res 2010; 16:800-13; PMID:20103663; http://dx.doi.org/10.1158/1078-0432.CCR-09-2730
   PubMed Web of Science ®Google Scholar
• Tallerico R, Todaro M, Di Franco S, Maccalli C, Garofalo C, Sottile R, Palmieri C, Tirinato L, Pangigadde PN, La Rocca R, et al. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J Immunol 2013; 190:2381-90; PMID:23345327; http://dx.doi.org/10.4049/jimmunol.1201542
   PubMed Web of Science ®Google Scholar
• Pietra G, Manzini C, Vitale M, Balsamo M, Ognio E, Boitano M, Queirolo P, Moretta L, Mingari MC. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. Int Immunol 2009; 21:793-801; PMID:19491215; http://dx.doi.org/10.1093/intimm/dxp047
   PubMed Web of Science ®Google Scholar
• Castriconi R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D, Spaziante R, Bellora F, et al. NK cells recognize and kill human glioblastoma cells with stem cell-like properties. J Immunol 2009; 182:3530-9; PMID:19265131; http://dx.doi.org/10.4049/jimmunol.0802845
   PubMed Web of Science ®Google Scholar
• Todaro M, D'Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, et al. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 2009; 182:7287-96; PMID:19454726; http://dx.doi.org/10.4049/jimmunol.0804288
   PubMed Web of Science ®Google Scholar
• Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13:145-9; PMID:23348417; http://dx.doi.org/10.1038/nri3365
   PubMed Web of Science ®Google Scholar
• Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-74; PMID:15771571; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115526
   PubMed Web of Science ®Google Scholar
• Orr MT, Lanier LL. Natural killer cell education and tolerance. Cell 2010; 142:847-56; PMID:20850008; http://dx.doi.org/10.1016/j.cell.2010.08.031
   PubMed Web of Science ®Google Scholar
• Conti L, Lanzardo S, Arigoni M, Antonazzo R, Radaelli E, Cantarella D, Calogero RA, Cavallo F. The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells. FASEB J 2013; 27:4731-44; PMID:23970797; http://dx.doi.org/10.1096/fj.13-230201
   PubMed Web of Science ®Google Scholar
• Porzia A, Lanzardo S, Citti A, Cavallo F, Forni G, Santoni A, Galandrini R, Paolini R. Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies. J Immunol 2010; 184:4170-7; PMID:20220087; http://dx.doi.org/10.4049/jimmunol.0903375
   PubMed Web of Science ®Google Scholar
• Lanzardo S, Conti L, Rooke R, Ruiu R, Accart N, Bolli E, Arigoni M, Macagno M, Barrera G, Pizzimenti S, et al. Immunotargeting of Antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer. Cancer Res 2016; 76:62-72; PMID:26567138; http://dx.doi.org/10.1158/0008-5472.CAN-15-1208
   PubMed Web of Science ®Google Scholar
• Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, et al. NK cells preferentially target tumor cells with a cancer stem cell phenotype. J Immunol 2015; 195:4010-9; PMID:26363055; http://dx.doi.org/10.4049/jimmunol.1500447
   PubMed Web of Science ®Google Scholar
• Kruse V, Hamann C, Monecke S, Cyganek L, Elsner L, Hubscher D, Walter L, Streckfuss-Bömeke K, Guan K, Dressel R. Human induced pluripotent stem cells are targets for allogeneic and autologous Natural Killer (NK) cells and killing is partly mediated by the activating NK receptor DNAM-1. PLoS One 2015; 10:e0125544; PMID:25950680; http://dx.doi.org/10.1371/journal.pone.0125544
   PubMed Web of Science ®Google Scholar
• Conti L, Lanzardo S, Ruiu R, Cadenazzi M, Cavallo F, Aime S, Geninatti Crich S. L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents. Oncotarget 2016; 7:66713-27; PMID:27579532; http://dx.doi.org/10.18632/oncotarget.10920
   PubMed Web of Science ®Google Scholar
• Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527-30; PMID:6823332; http://dx.doi.org/10.1038/301527a0
   PubMed Web of Science ®Google Scholar
• Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335:256-9; PMID:2970594; http://dx.doi.org/10.1038/335256a0
   PubMed Web of Science ®Google Scholar
• Brodin P, Lakshmikanth T, Mehr R, Johansson MH, Duru AD, Achour A, Salmon-Divon M, Kärre K, Höglund P, Johansson S. Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice. PLoS One 2010; 5:1-12; PMID:20957233; http://dx.doi.org/10.1371/journal.pone.0013174
   PubMed Web of Science ®Google Scholar
• Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 2009; 119:1251-63; PMID:19349689; http://dx.doi.org/10.1172/JCI36022
   PubMed Web of Science ®Google Scholar
• Bezman NA, Kim CC, Sun JC, Min-Oo G, Hendricks DW, Kamimura Y, Best JA, Goldrath AW, Lanier LL, Immunological Genome Project Consortium. Molecular definition of the identity and activation of natural killer cells. Nat Immunol 2012; 13:1000-9; PMID:22902830; http://dx.doi.org/10.1038/ni.2395
   PubMed Web of Science ®Google Scholar
• Wang B, Wang Q, Wang Z, Jiang J, Yu SC, Ping YF, Yang J, Xu SL, Ye XZ, Xu C, et al. Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells. Cancer Res 2014; 74:5746-57; PMID:25164008; http://dx.doi.org/10.1158/0008-5472.CAN-13-2563
   PubMed Web of Science ®Google Scholar
• Geninatti Crich S, Cadenazzi M, Lanzardo S, Conti L, Ruiu R, Alberti D, Cavallo F, Cutrin JC, Aime S. Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells. Nanoscale 2015; 7:6527-33; PMID:25786779; http://dx.doi.org/10.1039/C5NR00352K
   PubMed Web of Science ®Google Scholar
• Rolla S, Marchini C, Malinarich S, Quaglino E, Lanzardo S, Montani M, Iezzi M, Angeletti M, Ramadori G, Forni G, et al. Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. Hum Gene Ther 2008; 19:229-40; PMID:18269312; http://dx.doi.org/10.1089/hum.2006.196
   PubMed Web of Science ®Google Scholar
• Conti L, Lanzardo S, Iezzi M, Montone M, Bolli E, Brioschi C, Maiocchi A, Forni G, Cavallo F. Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe binding alphav beta3 integrins. Contrast Media Mol Imaging 2013; 8:350-60; PMID:23613438; http://dx.doi.org/10.1002/cmmi.1529
   PubMed Web of Science ®Google Scholar
• Geninatti Crich S, Cutrin JC, Lanzardo S, Conti L, Kalman FK, Szabo I, Lago NR, Iolascon A, Aime S. Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model. Contrast Media Mol Imaging 2012; 7:281-8; PMID:22539398; http://dx.doi.org/10.1002/cmmi.492
   PubMed Web of Science ®Google Scholar
• Principe M, Ceruti P, Shih NY, Chattaragada MS, Rolla S, Conti L, Bestagno M, Zentilin L, Yang SH, Migliorini P, et al. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells. Oncotarget 2015; 6:11098-113; PMID:25860938; http://dx.doi.org/10.18632/oncotarget.3572
   PubMed Web of Science ®Google Scholar
• Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, Boles KS, Andrews DM, Smyth MJ, Colonna M. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J Exp Med 2008; 205:2965-73; PMID:19029380; http://dx.doi.org/10.1084/jem.20081752
   PubMed Web of Science ®Google Scholar
• Macagno M, Bandini S, Stramucci L, Quaglino E, Conti L, Balmas E, Smyth MJ, Lollini PL, Musiani P, Forni G, et al. Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice. J Immunol 2014; 192:5434-41; PMID:24790144; http://dx.doi.org/10.4049/jimmunol.1301248
   PubMed Web of Science ®Google Scholar
• Bandini S, Curcio C, Macagno M, Quaglino E, Arigoni M, Lanzardo S, Hysi A, Barutello G, Consolino L, Longo DL, et al. Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice. Oncoimmunology 2013; 2:e26137; PMID:24228231; http://dx.doi.org/10.4161/onci.26137
   PubMed Web of Science ®Google Scholar
• Conti L, De Palma R, Rolla S, Boselli D, Rodolico G, Kaur S, Silvennoinen O, Niccolai E, Amedei A, Ivaldi F, et al. Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-gammaR2. J Immunol 2012; 188:1011-8; PMID:22219326; http://dx.doi.org/10.4049/jimmunol.1004013
   PubMed Web of Science ®Google Scholar
• Regis G, Icardi L, Conti L, Chiarle R, Piva R, Giovarelli M, Poli V, Novelli F. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing. Leukemia 2009; 23:2102-8; PMID:19626047; http://dx.doi.org/10.1038/leu.2009.139
   PubMed Web of Science ®Google Scholar
• McGinnes K, Chapman G, Marks R, Penny R. A fluorescence NK assay using flow cytometry. J Immunol Methods 1986; 86:7-15; PMID:3944470; http://dx.doi.org/10.1016/0022-1759(86)90258-9
   PubMed Web of Science ®Google Scholar